These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 278471)

  • 61. Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo).
    Kølendorf K; Aaby P; Westergaard S; Deckert T
    Eur J Clin Pharmacol; 1978 Nov; 14(2):117-24. PubMed ID: 363432
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of aprotinin on insulin absorption and subcutaneous blood flow in type 1 (insulin-dependent) diabetes.
    Linde B; Gunnarsson R
    Diabetologia; 1985 Sep; 28(9):645-8. PubMed ID: 2415419
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insulin analogues with improved absorption characteristics.
    Brange J; Hansen JF; Langkjaer L; Markussen J; Ribel U; Sørensen AR
    Horm Metab Res Suppl; 1992; 26():125-30. PubMed ID: 1490679
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kinetics of subcutaneous NPH insulin in diabetics.
    Kølendorf K; Bojsen J
    Clin Pharmacol Ther; 1982 Apr; 31(4):494-500. PubMed ID: 7060331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Technics of radioimmunoassay for insulin.
    Glick SM
    N Engl J Med; 1973 May; 288(18):973. PubMed ID: 4693258
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.
    Hirayama H; Kasuya Y; Kobayashi T; Itoh T; Yagishita A; Katakura T; Isono K
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):595-609. PubMed ID: 6379146
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differences in immunologic activity among preparations of human insulin.
    Soeldner JS; Sawin CT; Silbert CK; Mitchell ML
    Metabolism; 1974 Mar; 23(3):209-14. PubMed ID: 4813953
    [No Abstract]   [Full Text] [Related]  

  • 68. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment.
    Dahl-Jørgensen K; Torjesen P; Hanssen KF; Sandvik L; Aagenaes O
    Diabetes; 1987 Jan; 36(1):1-5. PubMed ID: 3539672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Understanding insulin: the old and new.
    Wilson HK; Field JB
    Adv Intern Med; 1984; 29():357-84. PubMed ID: 6369929
    [No Abstract]   [Full Text] [Related]  

  • 70. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics of continuous subcutaneous insulin infusion.
    Lauritzen T; Pramming S; Deckert T; Binder C
    Diabetologia; 1983 May; 24(5):326-9. PubMed ID: 6347780
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enzyme immunoassay of total insulin in human serum containing anti-insulin antibodies.
    Kohno T; Ishikawa E; Sugiyama S; Nakamura S; Kamano M; Ichioka T; Nakajima K
    Clin Chim Acta; 1987 Feb; 163(1):105-12. PubMed ID: 2436836
    [No Abstract]   [Full Text] [Related]  

  • 73. [Various remarks concerning determination of insulinemia by the Hales and Randle technic].
    Weryha A; Warter J
    Rev Med Liege; 1968 Oct; ():Suppl 1:39-43. PubMed ID: 5712333
    [No Abstract]   [Full Text] [Related]  

  • 74. [Plasma IRI--assay method and its significance].
    Kanazawa Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():3-6. PubMed ID: 2192127
    [No Abstract]   [Full Text] [Related]  

  • 75. Modeling absorption kinetics of subcutaneous injected soluble insulin.
    Mosekilde E; Jensen KS; Binder C; Pramming S; Thorsteinsson B
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):67-87. PubMed ID: 2654357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Massage-enhanced insulin absorption--increased distribution or dissociation of insulin?
    Linde B; Philip A
    Diabetes Res; 1989 Aug; 11(4):191-4. PubMed ID: 2696618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of accidental intramuscular injection on insulin absorption in IDDM.
    Frid A; Gunnarsson R; Güntner P; Linde B
    Diabetes Care; 1988 Jan; 11(1):41-5. PubMed ID: 3276476
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of aprotinin on regional absorption of soluble human insulin.
    Owens DR; Vora JP; Birtwell J; Luzio S; Hayes TM
    Br J Clin Pharmacol; 1988 Apr; 25(4):453-6. PubMed ID: 2454647
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
    Kemmer FW; Sonnenberg G; Cüppers HJ; Berger M
    Diabetes Care; 1982; 5 Suppl 2():23-8. PubMed ID: 6765535
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Estimation of insulin antibodies with 125I-insulin in vitro.
    Balázsi I; Stützel M; Lang I; Littmann L
    Rev Roum Med Intern; 1974; 11(1):95-7. PubMed ID: 4407676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.